Sergei Tjulandin

Georgetown University US

0000-0001-9807-2229

348

Publications

28,288

Citations

H-Index

i10-Index

17.0

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

346 total

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle, Val Gebski, Richard T. Penson et al. - The Lancet Oncology, 2017

Cited by 1,850 OpenAlex

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante et al. - New England Journal of Medicine, 2013

Cited by 6,584 OpenAlex

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study PDF

Bella Kaufman, John R. Mackey, Michael Clemens, P. P. Bapsy, Ashok K. Vaid et al. - Journal of Clinical Oncology, 2009

Cited by 849 OpenAlex

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer PDF

Marshall R. Posner, Diáne Hershock, C. Blajman, E. Mickiewicz, Eric Winquist et al. - New England Journal of Medicine, 2007

Cited by 1,699 OpenAlex

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group PDF

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla et al. - Journal of Clinical Oncology, 2006

Cited by 1,931 OpenAlex

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer PDF

William J. Gradishar, Sergei Tjulandin, Neville Davidson, Heather Shaw, Neil Desai et al. - Journal of Clinical Oncology, 2005

Cited by 2,115 OpenAlex

Research Topics

Colorectal Cancer Treatments and Studies (65) Gastric Cancer Management and Outcomes (62) Cancer Treatment and Pharmacology (47) Lung Cancer Treatments and Mutations (46) HER2/EGFR in Cancer Research (43)

Affiliations

Roche (Switzerland)

CH 2013 - 2009

Universitat Autònoma de Barcelona

ES 2014 - 2014

National Health Service

GB 2009 - 2009

BC Cancer Agency

CA 2015 - 2015

Academy of Medical Sciences

GB 2012 - 2012

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Sergei Tjulandin

Publication & Citation Trends

Publications

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study PDF

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer PDF

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group PDF

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer PDF

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back